Outcomes of High Vs Physiological Intraocular Pressure During Cataract Surgery Using ACTIVE SENTRY
ACTIVESENTRY
1 other identifier
interventional
38
0 countries
N/A
Brief Summary
Cataract surgery is a widely performed procedure across the world that helps restore vision in many patients suffering from cataracts. Irrigation is an essential component of the surgery. Fluid is constantly circulated to help regulate temperature as heat is generated with ultrasound energy, to minimize tissue trauma, and to create an intraocular pressure (IOP) sufficient to keep the anterior chamber (AC) stable. In parallel, aspiration brings the components of the cataract closer to the surgical instrument. A balance between irrigation and aspiration during surgery is essential to maintain stability in the AC. However, an ideal flow rate, which influences IOP during surgery, is yet to be determined. Most recent studies with Centurion Active Sentry show that there is similar efficiency between higher and lower IOP settings. Traditionally, high-flow rates have been used in advanced cataracts and are believed to make space in the AC. However, they are known to create fluid turbulence and are associated with risks of tissue damage, including cell loss in one of the cornea's layers. High IOP during surgery has also been shown to cause damage to the optic nerve as well as to the retina. Distorting and stretching the AC during phacoemulsification have also been associated with increased pain experienced by the patient. Comfort can be achieved by lowering pressure levels. Low-flow rates have a better safety profile, reduce IOP and pressure fluctuations while offering equal efficiency, including comparable surgical time. Using central corneal thickness (CCT) as an indicator of corneal trauma, it has been shown that patients that have had surgery with low-flow rates present no change in the CCT postoperatively as opposed to patients in the high-flow rates. As less fluid turbulence is created with low-flow rates, there is decreased risk of fragment contact with the cornea's inner surface, thus reducing cell loss. Alcon Laboratories, Inc. developed Active Fluidics which allows to stabilize intraocular pressure and prevent IOP fluctuations as well as IOP surges during surgery. It is now further equipped with the Active Sentry handpiece which is integrated to the surgical instrument and acts as a sensor to pressure variation. It allows rapid feedback to maintain a stable AC. Our research project aims to assess the outcomes following phacoemulsification done with physiological IOP with the help of the Active Sentry handpiece compared to traditional high IOP levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2024
CompletedFirst Posted
Study publicly available on registry
September 25, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedSeptember 25, 2024
September 1, 2024
4 months
September 22, 2024
September 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Central corneal thickness at 1 day postoperatively
Using central corneal thickness (CCT) as an indicator of corneal trauma, it has been shown that patients that have had surgery with low-flow rates present no change in the CCT postoperatively. CCT will be measured using a pachymetry (Normal CCT range 540µm ± 50).
1 day postoperatively
Secondary Outcomes (5)
Volume of balanced salt solution used during surgery
During surgery
Total ultrasound time and total aspiration time
During surgery
Endothelial cell loss (inner surface of the cornea)
At month 1 and month 3 postoperatively.
Central corneal thickness
1 week, 1 month and 3 months postoperatively
Corneal clarity
Day 1, week 1, month 1 and month 3 postoperatively
Other Outcomes (7)
Visual acuity
Day 1, week 1, month 1, and month 3 postoperatively
Low contrast evaluation
Day 1, week 1, month 1, and month 3 postoperatively
Intraocular pressure
Day 1, week 1, month 1, and month 3 postoperatively
- +4 more other outcomes
Study Arms (2)
Cataract surgery with Active Sentry
EXPERIMENTALCataract surgery with low IOP values (32mmHg)
High IOP
ACTIVE COMPARATORCataract surgery with high IOP (60mmHg) which is the average pressure at which cataract surgery is being performed currently
Interventions
Surgical instrument that detects changes in intraocular pressure and allows rapid feedback to stabilize pressure during cataract surgery.
Cataract surgery performed with high intraocular pressures
Eligibility Criteria
You may qualify if:
- No prior ocular surgery including corneal refractive surgery
- Bilateral visually significant cataract, similar in density (LOCS III grade 2+), undergoing uncomplicated cataract surgery
- Equal dilated pupil size ≥6mm, no use of pupil expansion devices
- Axial length 22-26mm, refractive error between -5.00D to +5.00D and cylinder ≤ 3.00D, normal K values \<47.00D
- Axial eye length cannot vary by more than 0.4 mm between eyes of an individual patient
- Normal CCT range 540µm ± 50
You may not qualify if:
- History of corneal disease or dystrophies
- Media opacification for reasons other than cataract
- Compromised zonular integrity or stability.
- Retinal and retinal vascular pathologies, age-related macular degeneration
- Glaucoma
- Patients with uncontrolled systematic diseases, including hypertension, diabetes, systemic cardiovascular diseases, and hematological diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Zhao Y, Li X, Tao A, Wang J, Lu F. Intraocular pressure and calculated diastolic ocular perfusion pressure during three simulated steps of phacoemulsification in vivo. Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2927-31. doi: 10.1167/iovs.08-2996. Epub 2009 Jan 24.
PMID: 19168897BACKGROUNDVasavada AR, Praveen MR, Vasavada VA, Vasavada VA, Raj SM, Asnani PK, Garg VS. Impact of high and low aspiration parameters on postoperative outcomes of phacoemulsification: randomized clinical trial. J Cataract Refract Surg. 2010 Apr;36(4):588-93. doi: 10.1016/j.jcrs.2009.11.009.
PMID: 20362850BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samir Jabbour, MD,CM,FRCSC
Centre hospitalier de l'Université de Montréal (CHUM)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ophthalmologist, Assistant clinical professor
Study Record Dates
First Submitted
September 22, 2024
First Posted
September 25, 2024
Study Start
October 1, 2024
Primary Completion
February 1, 2025
Study Completion
March 1, 2025
Last Updated
September 25, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share